Matrix metalloproteinases (MMPs) are a class of zinc-dependent endopeptidases that are capable of degrading almost all components of the extracellular matrix (ECM). The characteristic domain structure of MMP consists of four domains, of which the catalytic structural domain responsible for enzymatic activity contains a highly conserved zinc2+-binding region. In general, the major components of the ECM are collagens, and many other proteins that make up the basement membrane. Considering that MMPs play an important role in cancer, multiple matrix metalloproteinase inhibitors (MMPIs) have been studied by academics. Early inhibitors targeting MMP activity are designed to bind within the catalytic structural domain of these proteases. The initial therapeutic approaches are peptidomimetics, or compounds derived from the amino acid sequence of the MMP endogenous ligand.
To meet the growing demand for new structures for drug discovery projects, BOC Sciences has designed its dedicated chelators targeting matrix metalloproteinases library to generate small-molecule analogs of known ligase inhibitors with high bioactivity for the application in high-throughput screening (HTS) and high-content screening (HCS) programs.
Figure 1. Different biological mechanisms of intracellular localization of MMPs. (Bassiouni, W.; et al. 2021)
Figure 2. Mechanisms of regulation of intracellular MMPs activity. (Bassiouni, W.; et al. 2021)
BOC Sciences provides professional, rapid and high-quality services of Chelators Targeting Matrix Metalloproteinases Library design at competitive prices for global customers. Personalized and customized services of Chelators Targeting Matrix Metalloproteinases Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.